Literature DB >> 17113236

Rembrandt's Maria Bockenolle has a butterfly rash and digital deformities: overlapping syndrome of rheumatoid arthritis and systemic lupus erythematosus.

Satoshi Hayakawa1, Shihoko Komine-Aizawa, Shunzo Osaka, Toshihiro Iida, Junko Hayakawa, Susumu Nishinarita, Norimichi Nemoto.   

Abstract

Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are the most common autoimmune disorders, although they each have very different pathophysiology. In general, RA is considered to be a Th1-mediated disease, while SLE is a Th2-mediated disease. Thus, their overlapping, in so called "rhupus", is a rare condition. In Rembrandt van Rijn's (1606-1669) portrait of the middle-aged Maria Bockenolle, we have what may be the earliest depiction of a case of rhupus syndrome: the coexistence of a butterfly rash and digital deformities. This suggests the possible historical importance of an RA epidemic which took place in the early 17th century.

Entities:  

Mesh:

Year:  2006        PMID: 17113236     DOI: 10.1016/j.mehy.2006.09.055

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Historical perspective on the etiology of rheumatoid arthritis.

Authors:  Pouya Entezami; David A Fox; Philip J Clapham; Kevin C Chung
Journal:  Hand Clin       Date:  2011-02       Impact factor: 1.907

2.  Rhupus; unusual presentations.

Authors:  Ora Shovman; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2015-05-28       Impact factor: 2.980

3.  [Clinical features of patients with Rhupus syndrome].

Authors:  Z F Li; X Wu; L J Wu; C N Luo; Y M Shi; Y Zhong; X M Chen; X Y Meng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-18

4.  Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study.

Authors:  Jing Li; Honghua Wu; Xinxiang Huang; Dong Xu; Wenjie Zheng; Yan Zhao; Wanli Liu; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.